Remove Dermatitis Remove Medical Remove Pharmaceutical
article thumbnail

Get to Know Alys Pharmaceuticals, Inc.

The Dermatology Digest

Alys Pharmaceuticals, Inc. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. ” The post Get to Know Alys Pharmaceuticals, Inc. ” The post Get to Know Alys Pharmaceuticals, Inc.

article thumbnail

Weighing Risks Vs. Benefits of Systemic AD Treatments

The Dermatology Digest

Shared-decision making focused on weighing risks versus benefits is key when choosing the most appropriate systemic atopic dermatitis (AD) treatment for a patient, according to new research presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC. some of the biologics).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Oh, The Places Dermatology Will Go in 2024!

The Dermatology Digest

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”

article thumbnail

Off-label Pearl: Exploring the Role of Narrowband UVB Phototherapy Plus Oral JAK Inhibitors in Vitiligo

The Dermatology Digest

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best.

article thumbnail

Sneak Peek Inside the CSU Treatment Pipeline

The Dermatology Digest

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best.

article thumbnail

Think Twice: Is It Really AD?

The Dermatology Digest

Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.

article thumbnail

Isotretinoin: Current Thinking and Best Practices

The Dermatology Digest

Joshua Zeichner, MD, Associate Professor of Dermatology at the Mount Sinai Hospital in New York City, reviews the latest information on prescribing and monitoring isotretinoin for patients with severe nodulocystic acne and provides an update on the potential risks associated with this medication. Watch Now The Lowdown on Molluscum Nanette B.